WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price

A Wegovy injection pen.

Photographer: Shelby Knowles/Bloomberg

Novo Nordisk A/S struck a deal with WeightWatchers to boost access to its Wegovy obesity drug, just days after axing a collaboration with telehealth company Hims & Hers Health Inc.

WeightWatchers subscribers will be able to access Wegovy via CenterWell Pharmacy from July 1, Novo saidBloomberg Terminal Thursday. The drugmaker is also offering a $299 introductory price for self-pay patients who start on Wegovy, as well as for people who redeemed an earlier $199 offer and need a refill.